INNOCARE PHARMA LIMITED

Insiders InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Delayed Hong Kong S.E. Other stock markets 22:47:13 2024-05-13 EDT			5-day change	1st Jan Change
5.17 ^HKD	+0.19%		+0.78%	-25.11%

05-13	InnoCare Logs Loss in Q1	MT
03-29	InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InnoCare Elects CFO	12-18	MT
InnoCare Pharma Appoints Xin Fu as Chief Financial Officer	12-17	CI
Innocare Pharma Limited Announces the Appointment of Dandan Dong as Independent Non-Executive Director	23-10-11	CI
RemeGen Names CFO	23-09-28	MT
Innocare Pharma Limited Announces Board Changes	23-07-14	CI
InnoCare Pharma Limited Announces Shan Fu Resigned as A Non-Executive Director with Effect from 27 March 2023	23-03-27	CI
InnoCare CFO Resigns	23-01-02	MT
Innocare Pharma Limited Announces Executive Changes	22-03-31	CI
InnoCare Pharma Limited Announces Executive Changes	22-03-22	CI
InnoCare Pharma Appoints Dr. Sean Zhang as Chief Medical Officer	21-02-28	CI
InnoCare Pharma Limited Announces Change of the Chief Medical Officer	21-02-28	CI
InnoCare Pharma Limited Announces Change of Company Secretary	21-02-08	CI
InnoCare Pharma Limited Appoints Manish Tandon as Vice President of Business Development	20-10-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW